Search
Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Fighting Fungal Infections Using Smart Nanotech

They’re roughly the same size as a coronavirus particle, and 1000 times smaller than a human hair, yet newly engineered nanoparticles developed by scientists at the University of South Australia, are punching well above their weight when it comes to treating drug-resistant fungal infections.

Created in partnership with Monash University, the new nanobiotechnology (called ‘micelles’), has a remarkable ability to battle one of the most invasive and notoriously resistant fungal infections ­– Candida albicans. It’s a timely finding, especially given the significant rise of dangerous fungal infections in hospitals with countries overrun by COVID-19.

Candida albicans is an opportunistic pathogenic yeast that is extremely dangerous to people with compromised immune systems, particularly those in a hospital setting. Found on many surfaces, Candida albicans is notorious for its resilience to anti-fungal medicines. It is the most prevalent cause of fungal infections worldwide and can cause serious infections that can affect the blood, heart, brain, eyes, bones, and other parts of the body.

UniSA’s Professor Clive Prestidge, a Senior investigator, stated that the new polymer-based nanobiotechnology (micelles) could revolutionise current anti-fungal medicines. He noted that managing and treating invasive fungal infections is particularly challenging because so many fungal biofilms are resistant to contemporary antifungal drugs.

Fungal biofilms are surface-loving microbials that thrive on implanted devices such as catheters, prostheses and heart valves, making the presence of these devices a major risk factor for infection. In places like India – which has nearly 40,000 new COVID-19 infections every day – hospital resources are severely stretched, leaving healthcare workers are not only battling COVID-19 but also dealing with complacency and fatigue.

The unfortunate result is that infection control practices have deteriorated, putting patients on mechanical ventilation at greater risk of developing bacterial or fungal infections. As fungal biofilms tend to seed recurrent infections, finding ways to break and beat the infection cycle is critical, especially now.

The UniSA’s research has identified and developed smart micelles that have the ability to break down single and multi-species biofilms to significantly inhibit the growth of Candida albicans, one of the most virulent fungal species. They estimate that the new micelles could improve the efficacy of anti-fungal medicines by 100-fold, potentially saving the lives of millions of people worldwide.

Dr Nicky Thomas, co-investigator, says the new micelles present a breakthrough for treating invasive fungal infections. These micelles have a unique ability to solubilize and entrap a range of important antifungal drugs to significantly improve their performance and efficacy.

This is the first time that polymer-based micelles have been created with intrinsic capabilities to prevent fungal biofilm formation. As the results already show that the new micelles will remove up to 70 per cent of infection, this could be a real game-changer for treating fungal diseases.

Nanobiotechnology is a hybrid of nanotechnology and biotechnology in which traditional microtechnology is combined with a molecular biological approach. It has the potential to progress medical science and, as a result, improve healthcare practices around the world.

Nanobiotechnology integrates nanotechnology with biotechnology, including nanostructures’ unique physicochemical and biological features, as well as their applications in domains such as health and agriculture. One of the most promising technologies of the twenty-first century is nanobiotechnology. It is crucial in the development and implementation of numerous valuable tools for the study of life. Disease diagnostics, target-specific drug administration, and molecular imaging are some of the applications in medicine. It can also be used in agriculture and food.

Recent research shows that the global market for nanobiotechnology should grow from US$38.5 billion in 2021 to US$68.4 billion by 2026, a compound annual growth rate (CAGR) of 12.2% for the period of 2021-2026.

PARTNER

Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.

PARTNER

As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.

PARTNER

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.

SUPPORTING ORGANISATION

SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.

PARTNER

HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 

PARTNER

IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.